tiprankstipranks
Trending News
More News >

Nemaura Medical price target lowered to $2.50 from $7 at H.C. Wainwright

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Nemaura Medical to $2.50 from $7 and keeps a Buy rating on the shares. The firm expects the company to ramp up revenue via global partnerships in the coming years. but says its original projections for the sales trajectory may be too optimistic.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on NMRD:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue